Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-009724
Filing Date
2013-08-01
Accepted
2013-08-01 08:04:14
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20130723_10q.htm 10-Q 1165939
2 EXHIBIT 10.1 ex10-1.htm EX-10 34111
3 EXHIBIT 31.1 ex31-1.htm EX-31 10568
4 EXHIBIT 31.2 ex31-2.htm EX-31 10335
5 EXHIBIT 32.1 ex32-1.htm EX-32 4825
6 EXHIBIT 32.2 ex32-2.htm EX-32 4878
  Complete submission text file 0001437749-13-009724.txt   11835874

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS nby-20130630.xml EX-101.INS 1501386
8 EXHIBIT 101.SCH nby-20130630.xsd EX-101.SCH 53430
9 EXHIBIT 101.CAL nby-20130630_cal.xml EX-101.CAL 35057
10 EXHIBIT 101.DEF nby-20130630_def.xml EX-101.DEF 265720
11 EXHIBIT 101.LAB nby-20130630_lab.xml EX-101.LAB 413982
12 EXHIBIT 101.PRE nby-20130630_pre.xml EX-101.PRE 269507
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 131000950
SIC: 2834 Pharmaceutical Preparations